Table 2.
Characteristics and design quality of included reviews.
| Review and included studies | Participants, n (% male) | Sa (% male); TCb, (% male) |
Age (years); median (IQR), mean (SD), or range |
Design | Evidence quality (SIGNc) | |||
| Hamilton et al [28] | ||||||||
|
|
Scherr D, 2006 [37] | 20 |
S1, 14 (93); S2, 6 (83) |
50 (14) | FUUd | + | ||
|
|
Scherr D, 2009 [31] | 120 |
S, 66 (69.5); TC, 54 (72) |
66 (64-74) | RCTe | ++ | ||
|
|
Worringham C, 2011 [36] | 6 | —f | 53.6 (42-67) | FUU | + | ||
|
|
Blasco A, 2012 [32] | 203 (80) |
S, 102 (81); TC, 101 (79) |
60.6 (23.8) | RCT | ++ | ||
|
|
Seto E, 2012 [35] | 100 |
S, 50 (82); TC, 50 (76) |
53.5 (14) | CTg | + | ||
|
|
Varnfield M, 2014 [34] | 94 |
S, 53 (91); TC, 41 (83) |
52.13 (9.2) | RCT | + | ||
|
|
Forman D, 2014 [38] | 26 (77) | — | 59 (43-76); 33%>65 |
FUU | + | ||
| Nelson et al [30] | ||||||||
|
|
Fischer H, 2012 [39] | 47 | — | 50-59 | FUU | + | ||
| Perski et al [29] | ||||||||
|
|
Glasgow R, 2011 [33] | 270 | S1, 137 (54.7); S2, 133 (48.9) |
57.8 (9.3) | RCT | ++ | ||
|
|
Arden-Close E, 2015 [40] | 132 | S1, 137 (54.7); S2, 133 (48.9) |
57.8 (9.3) | FUU | + | ||
aS: mHealth study group.
bTC: traditional control group.
cSIGN: (-) low, (+) acceptable, (++) high quality.
dFUU: feasibility, usability, utility.
eRCT: randomized clinical trial.
fNot available.
gCT: controlled clinical trial.